Search -

Displaying 1 - 20 of 65

Sort: Relevancy | Date

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

Presentation Miami Valves 2024

Bioprosthetic Valve Degeneration After TAVR

Presenter: Renu Virmani

February 01, 2024

Presentation Miami Valves 2023

Bioprosthetic Valve Fracture in Patients Undergoing Valve-in-Valve TAVR for Failed Surgical Valves using SAPIEN 3/Ultra Valves: Insights From TVT Registry

Presenter: Santiago Garcia

February 02, 2023

Presentation CIT 2019

TAVR for Failed Aortic Bioprosthetic Surgical Valves: Clinical Overview

Presenter: David Zhao

March 28, 2019

Presentation

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

February 06, 2019

Presentation STS 2019

Aortic Valve Replacement in Bioprosthetic Failure: Insights from STS National Database

Presenter: Ankur Kalra

January 29, 2019

Presentation TCT 2018

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

Presenter: John G. Webb

September 23, 2018

Presentation

Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves

July 11, 2018

Presentation EuroPCR 2018

Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk

Presenter: Lars Sondergaard

May 25, 2018

Presentation

Valve-in-Valve TAVR vs Redo Surgical AVR for Bioprosthetic Aortic Valve Dysfunction

April 25, 2018

Presentation TVT 2017

A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability

Presenter: Martin B. Leon, Hendrik Treede

June 16, 2017

Presentation TVT 2017

Subclinical Leaflet Thrombosis in Surgical and Transcatheter Bioprosthetic Aortic Valves Cautionary Findings and Clinical Implications

Presenter: Martin B. Leon, Hendrik Treede, Raj Makkar

June 16, 2017

Presentation TVT 2017

Pitfalls in TAVR for Failing Stentless St. Jude Toronto 27mm Bioprosthetic AVR With Severe Aortic Insufficiency and No Significant Valvular Calcification

Presenter: Shigeru Saito, Jonathon M. White, Johannes Brechtken, MD

June 16, 2017

Presentation TVT 2017

Featured Lecture: The Spectrum of Bioprosthetic Valve Leaflet Thrombosis: From "Subclinical" Leaflet Thickening to Hemodynamic Changes and Clinical Events

Presenter: David W.M. Muller, Lars Sondergaard

June 16, 2017

Presentation TVT 2017

A Primer on Surgical Concepts of Structural Valve Deterioration and Guidelines for New Surgical Bioprosthetic Valves Implications for TAVR

Presenter: A. Pieter Kappetein

June 15, 2017

Presentation TVT 2017

The Use and Potential Advantages of Alternative TAVR Systems for Treating Aortic Bioprosthesis Failure (Acurate, Lotus, and Portico)

Presenter: Ran Kornowski, Mark J. Russo, Danny Dvir

June 15, 2017

Presentation TVT 2017

Expert Commentary: Evolut R in Degenerative Surgical Aortic Bioprostheses (VIVA Registry)

Presenter: Ran Kornowski

June 15, 2017

Presentation TVT 2017

Optimizing Outcomes of Valve-in-Valve TAVR: The Role of Bioprosthetic Valve Fracture

Presenter: Ran Kornowski, Mark J. Russo, David J. Cohen

June 15, 2017

Presentation TVT 2017

Case Outcome

Presenter: Molly Szerlip

June 15, 2017

Presentation TVT 2017

Expert Commentary: VIVID Registry and Technical Aspects

Presenter: Neil E. Moat

June 15, 2017

Advertisement

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Bioprosthetic Valve Degeneration After TAVR

Bioprosthetic Valve Fracture in Patients Undergoing Valve-in-Valve TAVR for Failed Surgical Valves using SAPIEN 3/Ultra Valves: Insights From TVT Registry

TAVR for Failed Aortic Bioprosthetic Surgical Valves: Clinical Overview

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

Aortic Valve Replacement in Bioprosthetic Failure: Insights from STS National Database

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves

Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk

Valve-in-Valve TAVR vs Redo Surgical AVR for Bioprosthetic Aortic Valve Dysfunction

A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability

Subclinical Leaflet Thrombosis in Surgical and Transcatheter Bioprosthetic Aortic Valves Cautionary Findings and Clinical Implications

Pitfalls in TAVR for Failing Stentless St. Jude Toronto 27mm Bioprosthetic AVR With Severe Aortic Insufficiency and No Significant Valvular Calcification

Featured Lecture: The Spectrum of Bioprosthetic Valve Leaflet Thrombosis: From "Subclinical" Leaflet Thickening to Hemodynamic Changes and Clinical Events

A Primer on Surgical Concepts of Structural Valve Deterioration and Guidelines for New Surgical Bioprosthetic Valves Implications for TAVR

The Use and Potential Advantages of Alternative TAVR Systems for Treating Aortic Bioprosthesis Failure (Acurate, Lotus, and Portico)

Expert Commentary: Evolut R in Degenerative Surgical Aortic Bioprostheses (VIVA Registry)

Optimizing Outcomes of Valve-in-Valve TAVR: The Role of Bioprosthetic Valve Fracture

Case Outcome

Expert Commentary: VIVID Registry and Technical Aspects

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content